Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 GeneticVariation disease BEFREE In SCA31 human brains, (UGGAA)<sub>n</sub>, the BEAN1 transcript of SCA31 mutation was found to form abnormal RNA structures called RNA foci in cerebellar Purkinje cell nuclei. 31755042 2019
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 Biomarker disease BEFREE Taking these findings together, we conclude that the RNA foci containing BEAN1-direction transcript (UGGAA)n are associated with PC degeneration in SCA31. 23607545 2013
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 GeneticVariation disease BEFREE Spinocerebellar ataxia type 31 (SCA31) is defined by the presence of an insertion mutation containing a TGGAA repeat within the intron of the brain-expressed, associated with NEDD4 (BEAN) gene. 22992774 2012
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 GermlineCausalMutation disease ORPHANET Spinocerebellar ataxia type 31 (SCA31) is defined by the presence of an insertion mutation containing a TGGAA repeat within the intron of the brain-expressed, associated with NEDD4 (BEAN) gene. 22992774 2012
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 Biomarker disease GENOMICS_ENGLAND "Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n." 19878914 2009
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 GermlineCausalMutation disease ORPHANET "Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n." 19878914 2009
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 Biomarker disease GENOMICS_ENGLAND "Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n." 19878914 2009
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 Biomarker disease GENOMICS_ENGLAND "Spinocerebellar ataxia type 31 is associated with ""inserted"" penta-nucleotide repeats containing (TGGAA)n." 19878914 2009
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 GermlineCausalMutation disease ORPHANET Redefining the disease locus of 16q22.1-linked autosomal dominant cerebellar ataxia. 17611710 2007
SPINOCEREBELLAR ATAXIA 31 (disorder)
0.630 Biomarker disease CTD_human
CUI: C0004134
Disease: Ataxia
Ataxia
0.100 Biomarker phenotype HPO
CUI: C0013362
Disease: Dysarthria
Dysarthria
0.100 Biomarker disease HPO
CUI: C0026838
Disease: Muscle Spasticity
Muscle Spasticity
0.100 Biomarker phenotype HPO
CUI: C0028738
Disease: Nystagmus
Nystagmus
0.100 Biomarker disease HPO
CUI: C0040822
Disease: Tremor
Tremor
0.100 Biomarker phenotype HPO
CUI: C0151888
Disease: Hyporeflexia
Hyporeflexia
0.100 Biomarker phenotype HPO
CUI: C0740279
Disease: Cerebellar atrophy
Cerebellar atrophy
0.100 Biomarker disease HPO
CUI: C0750937
Disease: Ataxia, Appendicular
Ataxia, Appendicular
0.100 Biomarker phenotype HPO
CUI: C0751837
Disease: Gait Ataxia
Gait Ataxia
0.100 Biomarker phenotype HPO
CUI: C1295585
Disease: Decreased vibratory sense
Decreased vibratory sense
0.100 Biomarker phenotype HPO
CUI: C1384666
Disease: hearing impairment
hearing impairment
0.100 Biomarker phenotype HPO
CUI: C1846176
Disease: Hyperactive deep tendon reflexes
Hyperactive deep tendon reflexes
0.100 Biomarker phenotype HPO
CUI: C1853394
Disease: Gaze-evoked horizontal nystagmus
Gaze-evoked horizontal nystagmus
0.100 Biomarker phenotype HPO
CUI: C1963184
Disease: Nystagmus, CTCAE 3.0
Nystagmus, CTCAE 3.0
0.100 Biomarker phenotype HPO
CUI: C4553743
Disease: Spasticity, CTCAE
Spasticity, CTCAE
0.100 Biomarker phenotype HPO